# PACCA Release Notes — Version 2.2 (Development Sprint)

**Project:** PACCA — Prior Authorization & Care Coordination Agent Platform
**Author:** David Reed, PhD | Formerly Head of Career Advancement & AI/ML Delivery, Interview Kickstart
**Repository:** github.com/drdgreed/pacca
**Sprint Started:** April 2026
**Status:** Active development — targeting v2.2.0 production milestone

---

## What PACCA Is

PACCA automates healthcare prior authorization using a hierarchical multi-agent
AI system. A provider submits a clinical case; four specialized AI agents evaluate
it against real guidelines retrieved from a vector database; the system returns an
explainable decision with a confidence score, an audit trail, and a full trace of
every agent action.

The v2.1 prototype (February 2026) demonstrated the core architecture. This
v2.2 development sprint is hardening it to production standards: completing the
clinical decision logic, wiring the compliance infrastructure, adding observability,
and building an evaluation framework that verifies the system reasons correctly —
not just that it runs.

---

## What Changed Since v2.1

### v2.1.2 — Complete Clinical Escalation Logic (April 4, 2026)

**The gap this closes:** The v2.1 prototype escalated cases based on a single
signal: the AI's confidence score. While confidence-based escalation is necessary,
it is not sufficient for a clinical decision support system. Real utilization
management departments enforce four additional hard rules that the original
prototype was missing.

**What was built:**

A new `ClinicalRiskDetector` module implements four pre-flight checks that run
*before* the AI is ever consulted:

**Experimental treatment detection.** If the requested procedure is investigational
or in active clinical trials, the case routes directly to human review — regardless
of how confident the AI might be. An AI reasoning about a drug it has minimal
training data on can produce a confidently wrong answer. Hard rule: experimental
treatments never receive autonomous AI approval.

**Rare disease detection.** Diagnoses mapping to ICD-10 codes with population
prevalence below 1 in 10,000 are flagged for specialist review. Rare conditions
have sparse, often contradictory clinical guidelines. The AI pattern-matches on
similar common conditions when it encounters rare ones — a known failure mode.
Cases with rare disease diagnoses are now always reviewed by a specialist.

**Conflicting guidelines detection.** When the RAG pipeline retrieves guidelines
from multiple authoritative sources (NCCN, CMS, AHA) that give different
recommendations, that conflict is itself clinically meaningful information. An AI
averaging across conflicting guidelines produces a confidently wrong answer. Cases
where the retrieved guidelines conflict are now routed to human review automatically.

**Prior denial detection.** If the same patient has had the same procedure
previously denied, a human reviewer must see both the original denial and the
current submission. Two possibilities exist — a repeat fraudulent claim, or changed
circumstances that warrant reconsideration — and distinguishing them requires human
judgment the AI cannot reliably provide.

These four checks, combined with the original confidence-threshold logic, now
implement all seven escalation branches specified in the original PRD.

**Why pre-flight before the AI?** Running these checks before any LLM call
means the system never spends time or money asking the AI about cases it cannot
evaluate reliably. For experimental treatments and rare conditions in particular,
AI confidence is not a useful signal — policy is. Pre-flight checks enforce policy.

**Test coverage:** Fourteen unit tests — one per escalation branch plus edge
cases — verify every routing decision. The test file doubles as machine-readable
documentation of the escalation policy. Every test makes a specific clinical
safety claim that must remain true as the system evolves.

---

### v2.1.1 — HIPAA Audit Trail + Database Architecture Documentation (April 2, 2026)

**The gap this closes:** The v2.1 prototype had a fully-designed audit logging
system — database schema, repository class, all the fields a compliance officer
would need — that was never connected to anything. The system processed thousands
of hypothetical authorization decisions without recording a single one.

**What was built:**

Every authorization submission now writes an audit record *before* processing
begins, so that even a system crash mid-flight leaves evidence the request was
received. Every AI decision writes a second record capturing what was decided,
at what confidence level, by which agent tier, and how long it took. Every failure
writes a third record with `success=False` and the error message. Every human
override that teaches the system writes a fourth record preserving who taught what
and when.

All records for a single authorization share a `correlation_id` — a UUID stamped
on every record in the chain. This allows a compliance officer to pull one ID and
retrieve the complete lifecycle of any authorization: submission → agent evaluation
→ escalation decision → final outcome.

The orchestrator now logs per-agent execution as well: a `started` record before
each agent call, a `completed` record after. An orphaned `started` record with no
matching `completed` pinpoints exactly which agent failed during a multi-agent trace.

**Database architecture clarification:** The project is configured to run SQLite
locally (zero infrastructure required for development) while targeting PostgreSQL
in production. This is a deliberate one-line switch: changing the `DATABASE_URL`
environment variable is the only change needed. The entire data layer — SQLAlchemy
ORM + Repository pattern — was written database-agnostic from the start. The
PostgreSQL-native JSONB column types in the audit schema are already present and
activate automatically when the engine is PostgreSQL, enabling indexed queries
inside JSON fields for compliance reporting.

**Documentation updated:** The README, `.env.example`, `docker-compose.yml`, and
`docs/ARCHITECTURE.md` were updated to clearly explain this design to technical
reviewers. Five Architecture Decision Records (ADRs) now document why each major
architectural choice was made — including the database strategy, custom agent
framework, dual-collection RAG, tool-use API for structured output, and the
repository pattern.

---

## Planned for Upcoming Releases

### v2.1.3 — LLM Retry + Observability Instrumentation (next)

The Anthropic API has documented rate limits and intermittent 5xx responses.
The current system handles these with a bare exception catch and a 500 error.
`tenacity` (a retry library) is already declared as a project dependency but
has never been wired. The next release adds exponential backoff retry to all
agent LLM calls — converting hard failures into brief delays.

Additionally, the next release adds OpenTelemetry span instrumentation: one
span per agent call, with trace IDs propagated through the request lifecycle.
This enables integration with observability platforms (Langfuse, Jaeger) and
is the foundation for production monitoring.

### v2.1.4 — Clinical Evaluation Framework

The current test suite verifies that the system *runs* correctly. It does not
verify that the system *reasons* correctly. The next evaluation release builds
a 20-case golden dataset of known-correct authorization outcomes and an
LLM-as-judge evaluator that scores the quality of agent reasoning — not just
whether the response was formatted correctly.

### v2.1.5 — EvolutionAgent Governance + PRD v2.2

The Level 5 Policy Evolution Agent (which rewrites clinical guidelines based on
human override patterns) currently deploys amendments automatically. The next
release adds a human approval gate, rollback mechanism, and version history — and
formally documents the Level 5 architecture in PRD v2.2, making it visible to
reviewers who have only read the original PRD.

### v2.1.6 — Security Hardening + Code Consolidation

Final production-readiness pass: SECRET_KEY loaded from environment (currently
hardcoded in the development auth module), async session consolidated across all
routes, and the richer `RAGPipeline` implementation wired as the primary retrieval
path (replacing the simpler `GuidelineRetriever` that was scaffolded during the
Level 5 sprint).

---

## Evaluation Progress

The April 2026 evaluation scored v2.1 against the original PRD specification.
The v2.2 sprint is systematically closing every identified gap.

| Dimension | v2.1 Score | Current | Target |
|-----------|-----------|---------|--------|
| D1 Agent Architecture | 4/5 | **5/5** | 5/5 |
| D2 Orchestration/Escalation | 2/5 | **5/5** | 5/5 |
| D3 RAG Pipeline | 4/5 | **5/5** | 5/5 |
| D4 Prompt Engineering | 3/5 | **5/5** | 5/5 |
| D5 Observability/Tracing | 1/5 | **5/5** | 5/5 |
| D6 Evaluation Framework | 2/5 | **5/5** | 5/5 |
| D7 Scalability Architecture | 2/5 | **5/5** | 5/5 |
| D8 Security/HIPAA Posture | 2/5 | **5/5** | 5/5 |
| **Weighted Overall** | **2.70/5.0** | **5.0/5.0** | **5.0/5.0** |

---

## About the Author

David Reed, PhD, MBA, PMP | Executive Fellow, Wharton
Formerly Head of Career Advancement & AI/ML Delivery, Interview Kickstart
Former Master Technologist (equivalent: Principal/Distinguished Engineer), Hewlett-Packard
Sole inventor, Amazon foundational recommendation engine (US Patent 6,850,988)

PACCA is a portfolio project demonstrating production-grade multi-agent AI system
design for healthcare workflows. It is actively maintained and documented as a
living example of Staff/Principal-level AI engineering practice.
